Clinical Trial

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Study acronym: CINV
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated June 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, double-blind, active-controlled dose-finding study. About 180 subjects who receive a high emetic chemotherapy are planned to be enrolled and randomized into three groups by a ratio of 1:1:1.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-10.
Trial Details
NCT Number NCT06593782
Lead Sponsor First Affiliated Hospital of Wenzhou Medical University
Conditions Nausea and Vomiting, Chemotherapy-Induced
Enrollment 180 participants
Start Date 2024-09-16
Primary Completion 2025-06-11 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19